Discovery Labs — Now Accepting Applications

Where clinical
insight meets
strategy.

Academically anchored. Commercially focused.

BlueBridge Discovery Labs brings together leading academic medical center faculty, multidisciplinary clinicians, and your team for a structured co-creation session that sharpens your evidence strategy and advances your program.

Schedule a Discovery Lab Learn more
Anchored in Academic Medical Center Network
Designed for Biotech & Pharma

A think-tank format unlike any advisory board.

Discovery Labs are structured strategy sessions that bring real clinical minds into your development process — not as passive consultants, but as co-creators. The result is actionable clarity on your most consequential decisions.

Co-created agenda

We work with you before the session to select the right topics, questions, and participants — ensuring the day drives decisions, not just discussion.

Multidisciplinary input in one room

Physicians, pharmacists, nurses, APPs, and administrators who shape real clinical adoption — not just high-profile KOLs.

Strategic outputs, not summaries

Walk away with trial design input, Target Product Profile refinement, indication prioritization, and clear next steps your team can act on.

Academic independence, commercial speed

Academic medical center credibility that for-profit competitors can't replicate — delivered without institutional red tape or multi-month contracting cycles.

Built for
the moment that matters.

Discovery Labs are designed for different stages of development — with format and depth matched to your decision horizon and budget.

Series A

Investor-Ready Development Framing

High-level development pathway with rough trial size, cost, and timeline. Academic medical center validation increases investor confidence immediately.

Series B / C

Full Discovery Lab Strategy Workshop

Indication prioritization, protocol design, regulatory pathway analysis. Fluid agenda, collaborative environment, and multidisciplinary clinical input.

Mid-size Pharma

Medical Strategy & Evidence Planning

Think-tank sessions for Target Product Profile input, evidence gap analysis, and co-creation of trial design at the TPP stage.

Investors

Portfolio Due Diligence & Strategy

For smaller VC funds and family offices that lack in-house clinical expertise. Portfolio-level development strategy sessions and fund advisory.

"
The easiest part is finding the expert. The hardest part is operationalizing.

— Medical Affairs Leader, Large Pharma · BlueBridge Discovery Interview

How a Discovery
Lab works.

From first conversation to final synthesis — a streamlined process designed to move fast and deliver real decisions.

01

Intake & Scoping

We learn your program, your gaps, and your decisions. Together we define the right scope and participant mix for your stage.

02

Agenda Co-Creation

We design the session with you — not for you. Topics, formats, and faculty selected around your actual strategic questions.

03

Lab Session

A structured, facilitated session with leading academic faculty and practice-realistic clinicians. Collaborative, not performative.

04

Synthesis & Follow-Through

Actionable outputs your team can act on: decision matrices, TPP input, trial design changes, and a clear path forward.

The BlueBridge Difference

Academic credibility.
Commercial speed.

Academic
Excellence

The only partner combining deep academic medical center relationships with the speed and autonomy biotech buyers actually need.

10+
Stakeholder interviews across buyer segments
Zero
Direct competitors with this academic anchor

What no
competitor can offer.

BlueBridge exists because the market needed a partner who moves fast and carries real academic credibility. Not one or the other.

Deep academic medical center relationships

Procurement actively prefers academic centers. Academic faculty credibility drives investor confidence in ways for-profit firms can't replicate.

Practice-realistic voices, not just KOLs

We include pharmacists, APPs, nurses, and administrators who actually shape clinical adoption — the voices most advisory boards miss.

Fast contracting, no red tape

Biotech buyers can't wait on institutional contracting cycles. BlueBridge delivers academic network access without institutional bureaucracy or slow contracting cycles.

Insight + follow-through, not just meetings

We're not a meeting logistics shop. Discovery Labs end with structured synthesis, decision frameworks, and clear next steps.

Meet the
founding team.

Ty Rorick, Founding Partner

Founding Partner

Ty Rorick

Former COO · Operations & Strategic Growth

Ty Rorick is a seasoned executive and former Chief Operating Officer who brings deep expertise in operations, leadership, and strategic growth. Over the course of his career, he has led organizations through periods of significant transformation — improving efficiency, strengthening teams, and delivering measurable results.

Known for his steady leadership style and ability to align strategy with execution, Ty now partners with businesses to streamline performance, navigate change, and position themselves for long-term success. In his consulting work, he advises leaders on strategy, execution, and performance improvement — helping organizations operate more effectively and achieve their goals.

Operational Excellence Strategic Growth Organizational Leadership Change Management

Ready to run a
Discovery Lab?

Tell us about your program and where you are in development. We'll scope the right format and get you a proposal within a week.

BlueBridge Clinical · Anchored in Academic Medicine